FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1231753002: Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Defined. Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5074134012 Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
5074135013 Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet en Synonym Active Case insensitive SNOMED CT core
5074136014 Acetaminophen 325 mg and chlorzoxazone 500 mg and diclofenac potassium 50 mg oral tablet en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Is a Chlorzoxazone and diclofenac and paracetamol only product in oral dose form true Inferred relationship Some
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Some
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has unit of presentation Tablet true Inferred relationship Some
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has precise active ingredient Diclofenac potassium true Inferred relationship Some 1
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has BoSS Diclofenac potassium true Inferred relationship Some 1
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has precise active ingredient Paracetamol true Inferred relationship Some 2
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has BoSS Paracetamol true Inferred relationship Some 2
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has precise active ingredient Chlorzoxazone true Inferred relationship Some 3
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has BoSS Chlorzoxazone true Inferred relationship Some 3
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 3
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian dialect reference set

Strength reference set

Back to Start